Resultados de la búsqueda 551-560 de 3433 para anti-TNF drugs
The purposes of this study are to determine the safety and feasibility of autologous platelet-rich plasma for the treatment of vulvar lichen sclerosus, and to ...
The purpose of this post-approval study is to further evaluate the long-term safety and effectiveness of Medtronic DBS therapy for epilepsy on seizure reduction ...
Collection of tissue and blood from patients with residual disease after neoadjuvant systemic therapy for breast cancer. We hope to use these samples to ...
Thermal ablation for tumor treatment. American College of Radiology. https://www.radiologyinfo.org/en/info/thermal-ablation-therapy. Nov. 3, 2023 ...
Finally, this study examines the effect of therapy intensification in patients who have RMS cancer with DNA mutations to see if their outcomes can be improved.
https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and ... medications. Accessed May 12, 2021. Antidepressants — Pediatric dosing ...
... therapy participating in a previous Celgene sponsored or Celgene alliance ... therapy in patients with newly diagnosed, treatment naïve PCNSL (Part B).
... treatment, post-treatment ... The purpose of this study is to determine the preliminary anti-tumor activity and confirm the safety of VV1 in combination with ...
Targeted drug therapies have greatly improved outcomes for patients with relapsed or refractory (R/R) chronic lymphocytic leukemia (CLL) and non-Hodgkin's ...
Treatment options for men with urinary leakage Oct. 20, 2022, 01:45 p.m. CDT. septiembre 2022. Mayo Clinic researchers identify drug resistance factors for ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?